Patients with CCL2 ≥ 320 pg/mL had significantly shorter OS, PCSS, and CFS than those with CCL2 < 320 pg/mL in our previous study [17]. The gene discussed is CCL2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.